Mitochondrial metabolism and cancer
Open Access
- 8 December 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cell Research
- Vol. 28 (3), 265-280
- https://doi.org/10.1038/cr.2017.155
Abstract
Glycolysis has long been considered as the major metabolic process for energy production and anabolic growth in cancer cells. Although such a view has been instrumental for the development of powerful imaging tools that are still used in the clinics, it is now clear that mitochondria play a key role in oncogenesis. Besides exerting central bioenergetic functions, mitochondria provide indeed building blocks for tumor anabolism, control redox and calcium homeostasis, participate in transcriptional regulation, and govern cell death. Thus, mitochondria constitute promising targets for the development of novel anticancer agents. However, tumors arise, progress, and respond to therapy in the context of an intimate crosstalk with the host immune system, and many immunological functions rely on intact mitochondrial metabolism. Here, we review the cancer cell-intrinsic and cell-extrinsic mechanisms through which mitochondria influence all steps of oncogenesis, with a focus on the therapeutic potential of targeting mitochondrial metabolism for cancer therapy.Keywords
This publication has 221 references indexed in Scilit:
- The Mitochondrial Chaperone TRAP1 Promotes Neoplastic Growth by Inhibiting Succinate DehydrogenaseCell Metabolism, 2013
- Sub-Sets of Cancer Stem Cells Differ Intrinsically in Their Patterns of Oxygen MetabolismPLOS ONE, 2013
- The Sedoheptulose Kinase CARKL Directs Macrophage Polarization through Control of Glucose MetabolismCell Metabolism, 2012
- The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue TypeCell Metabolism, 2012
- SCaMC-1 promotes cancer cell survival by desensitizing mitochondrial permeability transition via ATP/ADP-mediated matrix Ca2+ bufferingCell Death & Differentiation, 2011
- Succination of Keap1 and Activation of Nrf2-Dependent Antioxidant Pathways in FH-Deficient Papillary Renal Cell Carcinoma Type 2Cancer Cell, 2011
- Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthaseNature, 2011
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009
- The Hallmarks of CancerCell, 2000